Comparison of Oral Enalapril-Hydrochlorthiazide and Oral Nifedipine in Treating Postpartum l

Comparison of Oral Enalapril-Hydrochlorthiazide and Oral Nifedipine in Treating Postpartum Hypertension: An Open Label Randomised Control Trial - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062118

Enrollment

166

Registered

2024-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O135- Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating the puerperium

Interventions

Intervention1: enalapril: patient will receive enalapril 20 mg once daily for 7 days Control Intervention1: nifedipine: patient will receive nifedipine 10mg once daily for 7 days

Eligibility

Inclusion criteria

Inclusion criteria: patient with systolic blood pressure more than 140 mmHg will be included in the study

Exclusion criteria

Exclusion criteria: patients with renal artery stenosis, hepatic failure, pre pregnancy hypertension will be excluded from the study

Design outcomes

Primary

Measure	Time frame
systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHgTimepoint: systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHg	—

Secondary

Measure	Time frame
number of dosage of drug required, time to achieve target blood pressureTimepoint: at 18 hours	—

Countries

India

Contacts

Public ContactRaveena kumari Bhagat

ALL INDIA INSTITUTE OF MEDICAL SCIENCES PATNA

sangam.jha78@gmail.com09827388001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026